Drug intelligence / Profile preview

Olimel N9

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Intravenous, Parenteral
01

Overview

Olimel N9 is a triple-chamber bag parenteral nutrition (PN) formulation developed by Baxter. It consists of an olive oil-based lipid emulsion (ClinOleic), amino acids, and glucose. The formulation is specifically designed for patients with moderate metabolic stress who have high protein and moderate energy requirements. It is indicated for adults and children over two years of age when oral or enteral nutrition is impossible, insufficient, or contraindicated. Due to its high osmolarity (approximately 1420 mOsm/L), Olimel N9 must be administered through a central vein. It is available in versions with and without electrolytes, the latter of which is often utilized as intradialytic parenteral nutrition (IDPN) to provide protein, fatty acids, and calories to malnourished hemodialysis patients.

Brand names
Olimel N9
Other names
Olimel N9 without electrolytesOlimel N9 with electrolytesOlimel N9E

Beyond the preview

Go deeper on Olimel N9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olimel N9.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call